Press Release

Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients with HER2-Expressed Solid Tumors

Press Release

Bolt Biotherapeutics Appoints Dr. Nils Lonberg to its Scientific Advisory Board

Press Release

Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. Priti Hegde

Press Release

Bolt Biotherapeutics Presents Data At SITC Conference Showing Eradication of Large Tumors in Preclinical Studies

Press Release

Bolt Strengthens Scientific Advisory Board Through Addition of Drs. Lawrence Fong, Roy Herbst and Bruce Roth

Press Release

Randall Schatzman, Ph.D., joins Bolt Biotherapeutics as CEO and a member of the board of directors, bringing over 30 years of biotech industry leadership experience

Press Release

Bolt Biotherapeutics Presents Preclinical Proof of Concept Data at American Association for Cancer Research (AACR) Conference

Press Release

Bolt Biotherapeutics Completes $54 Million Series B Financing